Ads
related to: the therapy notestherapynotes.com has been visited by 100K+ users in the past month
Search results
Intra-Cellular Therapies Stock Launches 20% Into Breakout Territory On Depression Test Results
Investor's Business Daily· 39 minutes agoIntra-Cellular Therapies stock rocketed Tuesday after its drug, Caplyta, topped expectations in a...
Lexeo's LX2006 Gene Therapy Gets FDA Fast Track Designation; Stock Up In Pre-market
RTT News· 1 hour agoLexeo Therapeutics, Inc. (LXEO), a clinical stage genetic medicine company, announced Tuesday that the U.S. Food and Drug Administration has granted Fast Track designation to LX2006 gene therapy.
Lost & Found Grief Center hires Mark Miller, longtime OTC spokesman, as its new director
Springfield News-Leader via Yahoo News· 33 minutes agoMiller replaces Mike Woody, who retired in 2023. He will work with assistant executive director...
Trump mocked for falling asleep in court as hush money trial continues and stock plummets: Live
The Independent via Yahoo News· 9 minutes agoAs jury selection got underway in the New York criminal case, the former president appeared to...
Mark Cuban invests $100K into Brick soapmaker; 'Shark Tank effect' boosts Sorsoap sales
App.com | Asbury Park Press via Yahoo Finance· 4 hours agoHe offered $100,000 for 20%. Restiano and Staats countered: $100,000 for 15% and unlimited physical ...
Genentech axes Adaptimmune cell therapy deal as it presses ahead with staff cuts
FierceBiotech· 4 days agoIn the same week that Genentech confirmed it's cutting 3% of its staff, the Roche subsidiary has...
TD Cowen says sickle cell therapies may get higher CMS payments (NASDAQ:VRTX)
Seeking Alpha· 17 hours agoTD Cowen said recently approved gene therapies by Vertex (VRTX)/CRISPR (CRSP) and bluebird bio (BLUE) may get enhanced payments under proposed CMS guidelines. Read more here.
The Longevity Vacation: Poolside Lounging With an IV Drip
The Wall Street Journal· 13 hours agoFor some vacationers, the ideal getaway involves $1,200 ozone therapy or an $1,800 early-detection...
Ultragenyx says Angelman therapy is working, but safety questions remain
BioPharma Dive via Yahoo Finance· 1 day agoTreatment appeared to result in functional and cognitive gains in people with the neurological...
Robert W. Baird initates Intra-Cellular Therapies Inc
Knox Daily· 1 day agoRobert W. Baird initiated its Intra-Cellular Therapies Inc [ITCI] rating to an Outperform in a research note published on January 03, 2024; the price target was $83. A number ...
Ads
related to: the therapy notestherapynotes.com has been visited by 100K+ users in the past month
